🚀 VC round data is live in beta, check it out!
Clinica Baviera Valuation Multiples
Discover revenue and EBITDA valuation multiples for Clinica Baviera and similar public comparables like Rhoen Klinikum, BioLife Solutions, Lumexa Imaging, HCG Hospitals and more.
Clinica Baviera Overview
About Clinica Baviera
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
Founded
1992
HQ
Employees
882
Website
Financials (LTM)
EV
$1B
Clinica Baviera Financials
Clinica Baviera reported last 12-month revenue of $356M and EBITDA of $101M.
In the same LTM period, Clinica Baviera generated $101M in EBITDA and $51M in net income.
Revenue (LTM)
Clinica Baviera P&L
In the most recent fiscal year, Clinica Baviera reported revenue of $355M and EBITDA of $102M.
Clinica Baviera expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $356M | XXX | $355M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $315M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 89% | XXX | XXX | XXX |
| EBITDA | $101M | XXX | $102M | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 29% | XXX | XXX | XXX |
| EBIT Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| Net Profit | $51M | XXX | $50M | XXX | XXX | XXX |
| Net Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| Net Debt | — | — | $4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Clinica Baviera Stock Performance
Clinica Baviera has current market cap of $985M, and enterprise value of $1B.
Market Cap Evolution
Clinica Baviera's stock price is $61.51.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $985M | 0.0% | XXX | XXX | XXX | $3.09 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialClinica Baviera Valuation Multiples
Clinica Baviera trades at 2.8x EV/Revenue multiple, and 9.9x EV/EBITDA.
EV / Revenue (LTM)
Clinica Baviera Financial Valuation Multiples
As of April 19, 2026, Clinica Baviera has market cap of $985M and EV of $1B.
Equity research analysts estimate Clinica Baviera's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Clinica Baviera has a P/E ratio of 19.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $985M | XXX | $985M | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 2.8x | XXX | 2.8x | XXX | XXX | XXX |
| EV/EBITDA | 9.9x | XXX | 9.9x | XXX | XXX | XXX |
| EV/EBIT | 13.8x | XXX | 14.1x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.2x | XXX | XXX | XXX |
| P/E | 19.4x | XXX | 19.9x | XXX | XXX | XXX |
| EV/FCF | 31.1x | XXX | 18.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Clinica Baviera Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Clinica Baviera Margins & Growth Rates
Clinica Baviera's revenue in the last 12 month grew by 10%.
Clinica Baviera's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.
Clinica Baviera's rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Clinica Baviera's rule of X is 48% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Clinica Baviera Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 29% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 8% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 36% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 48% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 8% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 69% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Clinica Baviera Public Comps
See public comps and valuation multiples for other Hospitals & Clinics and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Clinica Baviera | XXX | XXX | XXX | XXX | XXX | XXX |
| Rhoen Klinikum | XXX | XXX | XXX | XXX | XXX | XXX |
| BioLife Solutions | XXX | XXX | XXX | XXX | XXX | XXX |
| Lumexa Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| HCG Hospitals | XXX | XXX | XXX | XXX | XXX | XXX |
| Saudi German Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Clinica Baviera M&A Activity
Clinica Baviera acquired XXX companies to date.
Last acquisition by Clinica Baviera was on XXXXXXXX, XXXXX. Clinica Baviera acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Clinica Baviera
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialClinica Baviera Investment Activity
Clinica Baviera invested in XXX companies to date.
Clinica Baviera made its latest investment on XXXXXXXX, XXXXX. Clinica Baviera invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Clinica Baviera
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Clinica Baviera
| When was Clinica Baviera founded? | Clinica Baviera was founded in 1992. |
| Where is Clinica Baviera headquartered? | Clinica Baviera is headquartered in Spain. |
| How many employees does Clinica Baviera have? | As of today, Clinica Baviera has over 882 employees. |
| Is Clinica Baviera publicly listed? | Yes, Clinica Baviera is a public company listed on Bolsa de Madrid. |
| What is the stock symbol of Clinica Baviera? | Clinica Baviera trades under CBAV ticker. |
| When did Clinica Baviera go public? | Clinica Baviera went public in 2000. |
| Who are competitors of Clinica Baviera? | Clinica Baviera main competitors are Rhoen Klinikum, BioLife Solutions, Lumexa Imaging, HCG Hospitals. |
| What is the current market cap of Clinica Baviera? | Clinica Baviera's current market cap is $985M. |
| What is the current revenue of Clinica Baviera? | Clinica Baviera's last 12 months revenue is $356M. |
| What is the current revenue growth of Clinica Baviera? | Clinica Baviera revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Clinica Baviera? | Current revenue multiple of Clinica Baviera is 2.8x. |
| Is Clinica Baviera profitable? | Yes, Clinica Baviera is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Clinica Baviera? | Clinica Baviera's last 12 months EBITDA is $101M. |
| What is Clinica Baviera's EBITDA margin? | Clinica Baviera's last 12 months EBITDA margin is 28%. |
| What is the current EV/EBITDA multiple of Clinica Baviera? | Current EBITDA multiple of Clinica Baviera is 9.9x. |
| What is the current FCF of Clinica Baviera? | Clinica Baviera's last 12 months FCF is $32M. |
| What is Clinica Baviera's FCF margin? | Clinica Baviera's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Clinica Baviera? | Current FCF multiple of Clinica Baviera is 31.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.